TARS logo

Tarsus Pharmaceuticals, Inc. (TARS) return on equity

annual ROE:

-54.83%+14.88%(+21.35%)
December 31, 2024

Summary

  • As of today (September 8, 2025), TARS annual return on equity is -54.83%, with the most recent change of +14.88% (+21.35%) on December 31, 2024.
  • During the last 3 years, TARS annual ROE has fallen by -46.52% (-559.81%).
  • TARS annual ROE is now -559.81% below its all-time high of -8.31%, reached on December 31, 2021.

Performance

TARS ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTARSprofitability metrics

quarterly ROE:

-33.11%+6.29%(+15.96%)
June 30, 2025

Summary

  • As of today (September 8, 2025), TARS quarterly return on equity is -33.11%, with the most recent change of +6.29% (+15.96%) on June 30, 2025.
  • Over the past year, TARS quarterly ROE has increased by +35.99% (+52.08%).
  • TARS quarterly ROE is now -175.37% below its all-time high of 43.93%, reached on March 31, 2020.

Performance

TARS quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTARSprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

TARS ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+21.4%+52.1%
3 y3 years-559.8%-6.5%
5 y5 years-249.9%-190.9%

TARS ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-559.8%+21.4%-6.5%+55.0%
5 y5-year-559.8%+21.4%-934.7%+55.0%
alltimeall time-559.8%+21.4%-175.4%+55.0%

TARS ROE History

DateAnnualQuarterly
Jun 2025
-
-33.11%(-16.0%)
Mar 2025
-
-39.40%(-19.1%)
Dec 2024
-54.83%(-21.3%)
-48.70%(-14.8%)
Sep 2024
-
-57.14%(-17.3%)
Jun 2024
-
-69.10%(-6.1%)
Mar 2024
-
-73.59%(+0.1%)
Dec 2023
-69.71%(+101.9%)
-73.48%(+27.1%)
Sep 2023
-
-57.82%(+19.3%)
Jun 2023
-
-48.47%(+39.6%)
Mar 2023
-
-34.73%(+4.4%)
Dec 2022
-34.53%
-33.28%(-3.4%)
Sep 2022
-
-34.46%(+10.8%)
DateAnnualQuarterly
Jun 2022
-
-31.09%(+21.7%)
Mar 2022
-
-25.54%(+224.5%)
Dec 2021
-8.31%(-65.4%)
-7.87%(+20.0%)
Sep 2021
-
-6.56%(+105.0%)
Jun 2021
-
-3.20%(-65.1%)
Mar 2021
-
-9.17%(-60.6%)
Dec 2020
-24.01%(+53.2%)
-23.28%(-15.5%)
Sep 2020
-
-27.55%(+142.1%)
Jun 2020
-
-11.38%(-125.9%)
Mar 2020
-
43.93%(+287.4%)
Dec 2019
-15.67%(-73.7%)
11.34%
Dec 2018
-59.68%
-

FAQ

  • What is Tarsus Pharmaceuticals, Inc. annual return on equity?
  • What is the all time high annual ROE for Tarsus Pharmaceuticals, Inc.?
  • What is Tarsus Pharmaceuticals, Inc. annual ROE year-on-year change?
  • What is Tarsus Pharmaceuticals, Inc. quarterly return on equity?
  • What is the all time high quarterly ROE for Tarsus Pharmaceuticals, Inc.?
  • What is Tarsus Pharmaceuticals, Inc. quarterly ROE year-on-year change?

What is Tarsus Pharmaceuticals, Inc. annual return on equity?

The current annual ROE of TARS is -54.83%

What is the all time high annual ROE for Tarsus Pharmaceuticals, Inc.?

Tarsus Pharmaceuticals, Inc. all-time high annual return on equity is -8.31%

What is Tarsus Pharmaceuticals, Inc. annual ROE year-on-year change?

Over the past year, TARS annual return on equity has changed by +14.88% (+21.35%)

What is Tarsus Pharmaceuticals, Inc. quarterly return on equity?

The current quarterly ROE of TARS is -33.11%

What is the all time high quarterly ROE for Tarsus Pharmaceuticals, Inc.?

Tarsus Pharmaceuticals, Inc. all-time high quarterly return on equity is 43.93%

What is Tarsus Pharmaceuticals, Inc. quarterly ROE year-on-year change?

Over the past year, TARS quarterly return on equity has changed by +35.99% (+52.08%)
On this page